Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratner

Showing results (161-170 of 4,048) with videos related to

Pageof 405
Sort By:
Nature Biotechnology|March 7, 2018
Jury out on liquid biopsies for cancerMark Ratner
Nature Biotechnology|February 10, 2021
Light-activated genetic therapy to treat blindness enters clinicMark Ratner
Nature Biotechnology|March 2, 2021
Publisher Correction: Light-activated genetic therapy to treat blindness enters clinicMark Ratner
Nature Biotechnology|August 10, 2016
Genentech's PD-L1 agent approved for bladder cancerMark Ratner
Nature Biotechnology|June 10, 2015
Heart failure gene therapy disappoints but experts keep the faithMark Ratner
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Argininosuccinate synthetase of bovine liver: chemical and physical propertiesS Ratner
Blood|June 5, 2020
Predicting the future: adult T-cell leukemiaLee Ratner
American Annals of the Deaf|December 1, 1988
New tests for identifying hearing-impaired students with visual perceptual deficits: relationship between deficits and ability to comprehend sign languageV Ratner
Nature Biotechnology|October 8, 2005
New IGF drug stirs competition in growth factor segmentMark Ratner
Nature Reviews. Drug Discovery|May 3, 2005
Industry shrugs off NIH consulting banMark Ratner
Pageof 405

Showing results (161-170 of 4,048) with videos related to

Sort By:
Pageof 405
Nature Biotechnology|March 7, 2018
Jury out on liquid biopsies for cancerMark Ratner
Nature Biotechnology|February 10, 2021
Light-activated genetic therapy to treat blindness enters clinicMark Ratner
Nature Biotechnology|March 2, 2021
Publisher Correction: Light-activated genetic therapy to treat blindness enters clinicMark Ratner
Nature Biotechnology|August 10, 2016
Genentech's PD-L1 agent approved for bladder cancerMark Ratner
Nature Biotechnology|June 10, 2015
Heart failure gene therapy disappoints but experts keep the faithMark Ratner
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Argininosuccinate synthetase of bovine liver: chemical and physical propertiesS Ratner
Blood|June 5, 2020
Predicting the future: adult T-cell leukemiaLee Ratner
American Annals of the Deaf|December 1, 1988
New tests for identifying hearing-impaired students with visual perceptual deficits: relationship between deficits and ability to comprehend sign languageV Ratner
Nature Biotechnology|October 8, 2005
New IGF drug stirs competition in growth factor segmentMark Ratner
Nature Reviews. Drug Discovery|May 3, 2005
Industry shrugs off NIH consulting banMark Ratner
Pageof 405